Large pharmaceutical companies across the globe face rising costs and increasing complexity in regulatory requirements involved in bringing products to market. Data and analytics teams are embarking on robust clinical trials data repositories to boost R&D strategies to accelerate drug discovery, development, and streamline trial operations.
During this webinar, Mark Ramsey, former Chief Data and Analytics Officer at GSK, shares his insights on:
Fill in the form to watch this webinar.
Large pharmaceutical companies across the globe face rising costs and increasing complexity in regulatory requirements involved in bringing products to market. Data and analytics teams are embarking on robust clinical trials data repositories to boost R&D strategies to accelerate drug discovery, development, and streamline trial operations.
During this webinar, Mark Ramsey, former Chief Data and Analytics Officer at GSK, shares his insights on:
Fill in the form to watch this webinar.
Mark Ramsey has over 30 years experience in the successful design, development, implementation, and support of mission-critical systems leveraging data analytics and optimization to provide business advantage. Mark was the first Chief Data & Analytics Officer for GlaxoSmithKline plc, a multinational pharmaceutical company headquartered in London, and the world’s sixth-largest pharmaceutical company.
Megan leads product marketing for Tamr and is passionate about uncovering ways that companies can leverage their data as an asset. She has spent the past eight years in healthcare IT, most recently at Kyruus, the industry leader in provider search and scheduling solutions for health systems. Megan holds a B.A. in English from the University of Massachusetts, Amherst.